These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6951081)

  • 1. Mechanisms of immunologic eradication of a syngeneic guinea pig tumor. I. Quantitative analysis of adoptive immunity.
    Shu S; Hunter JT; Rapp HJ; Fonseca LS
    J Natl Cancer Inst; 1982 Apr; 68(4):673-80. PubMed ID: 6951081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of immunological eradication of a syngeneic guinea pig tumor: participation of a component(s) of recipient origin in the expression of systemic adoptive immunity.
    Shu S; Fonseca LS; Kato H; Zbar B
    Cancer Res; 1983 Jun; 43(6):2637-43. PubMed ID: 6342756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; van de Plas MM; Steerenberg PA; Kruizinga W; Ruitenberg EJ
    J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions.
    Shu S; Steerenberg PA; Hunter JT; Evans CH; Rapp HJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3499-506. PubMed ID: 7260913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell involvement in adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs.
    de Jong WH; Steerenberg PA; van de Plas MM; Kruizinga W; Ruitenberg J
    J Natl Cancer Inst; 1985 Sep; 75(3):483-9. PubMed ID: 3875751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. II. Influence of the local inflammatory response on immune reactivity.
    Key ME; Hanna MG
    J Natl Cancer Inst; 1981 Oct; 67(4):863-9. PubMed ID: 6944553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of tumor incidence by oncofetal products in a syngeneic hepatoma cell-spleen cell model.
    Mizejewski GJ; Macario AL
    Neoplasma; 1983; 30(1):23-34. PubMed ID: 6188067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME; Hanna MG
    J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour rejection in immunized guinea-pigs.
    Kolin A; Vacek J; Landi S
    Br J Exp Pathol; 1983 Oct; 64(5):542-7. PubMed ID: 6639873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against experimental toxoplasmosis by adoptive immunotherapy.
    Pavia CS
    J Immunol; 1986 Nov; 137(9):2985-90. PubMed ID: 3489780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.
    Dvorak HF; Dvorak AM; Manseau EJ; Wiberg L; Churchill WH
    J Natl Cancer Inst; 1979 Jun; 62(6):1459-72. PubMed ID: 286118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rejection of retrovirus-infected tumor cells in guinea pigs: effect on bystander tumor cells.
    Nagai A; Zbar B; Terata N; Hovis J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5783-8. PubMed ID: 6315216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria.
    Brunda MJ; Mathews HL; Ferguson HR; McClatchy JK; Minden P
    Cancer Res; 1980 Sep; 40(9):3211-3. PubMed ID: 6775802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological evaluation of immunologically mediated tumor regression of the line 10 guinea pig hepatocarcinoma.
    de Jong WH; Teppema JS; Wagenaar SS; Paques M; Steerenberg PA; Ruitenberg EJ
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 50(3):249-69. PubMed ID: 2870577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immunogenicity of line 10 guinea pig hepatocarcinoma cells after culture.
    Correll LL; Nielsen LD; Kelleher PJ; Harbell JW; Minden P
    J Natl Cancer Inst; 1983 Dec; 71(6):1343-6. PubMed ID: 6581367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
    Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic variants isolated from a mutagen-treated guinea pig fibrosarcoma.
    Zbar B; Sukumar S; Tanio Y; Terata N; Hovis J
    Cancer Res; 1984 Nov; 44(11):5079-85. PubMed ID: 6488168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor rejection mediated by an amphotropic murine leukemia virus.
    Zbar B; Nagai A; Terata N; Hovis J
    Cancer Res; 1983 Jan; 43(1):46-53. PubMed ID: 6182993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.